You are here: Industry Insights > Roche

News List

Roche nabs blockbuster FDA approval for Hemlibra, big label expansion for Gazyva fiercepharma
November 17, 2017
Hemlibra won the agency's backing to prevent or reduce bleeding in adults or children with hemophilia A who have developed antibodies called Factor VIII inhibitors.
Amgen, Merck, Roche get in on Syapse’s $30M round fiercebiotech
November 16, 2017
Syapse picked up $30 million in series D financing, funds it will use to bring its oncology precision medicine software to more healthcare providers.
Roche appoints Lara Bezerra as MD, Roche Pharma India expressbpd
November 15, 2017
Roche announced the appointment of Lara Bezerra as Managing Director for Roche Products (India). She succeeds Maturin Tchoumi who has now moved to Roche Finland in a new role.
EMA recommends approval of Roche's Ocrevus in relapsing forms of multiple sclerosis pharmafile
November 14, 2017
Roche has revealed that its humanised monoclonal antibody Ocrevus (ocrelizumab) received a positive recommendation from the Committee for Medical Products for Human Use (CHMP) in the treatment of active relapsing forms of multiple sclerosis.
Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS fiercepharma
November 13, 2017
Roche has also had issues winning coverage for some of its other new cancer drugs in the U.K., such as Tecentriq and Kadcyla.
Roche’s OCREVUS (ocrelizumab) gains positive CHMP opinion for relapsing forms of multiple sclerosis roche
November 13, 2017
Roche Corporation today announced that CHMP uses OCREVUS to take positive comment characteristics in patients with clinically or radiographically defined active forms of multiple sclerosis
Roche, Calico vet Hal Barron takes GSK R&D hot seat, as Vallance out fiercebiotech
November 09, 2017
Former Roche and Calico vet Hal Barron has become the new CSO and research chief at GlaxoSmithKline amid a shake-up from its new CEO Emma Walmsley.
Roche gives free access to cancer drug after Greek government altercation biospectrumasia
November 09, 2017
Roche gives free access to cancer drug after Greek government altercation The Greek government had introduced a levy of up to 25% on the turnover generated by patent-protected drugs as part of an ongoing bailout deal with international lenders.
Roche granted US approval for wider use of Alecensa pharmatimes
November 08, 2017
Roche group Genentech says its application to expand the use of Alecensa has been approved by US FDA.
NICE back Roche’s Tecentriq for CDF pharmatimes
November 02, 2017
The National Institute for Health and Care Excellence is recommending Roche’s Tecentriq for use within the Cancer Drugs Fund to treat advanced urothelial cancer in certain circumstances.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 45 46 Next page